Drug profile · INN
taliglucerase alfa
ELELYSO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
taliglucerase alfa (ELELYSO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
INN taliglucerase alfa
Brand ELELYSO
Route INTRAVENOUS
Formulation POWDER
ATC code A16AB11
Frequently asked questions
What is taliglucerase alfa?
taliglucerase alfa (ELELYSO) is an FDA-listed pharmaceutical active ingredient. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for taliglucerase alfa?
ELELYSO is a marketed brand name for taliglucerase alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of taliglucerase alfa?
taliglucerase alfa has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.